India  

Indians to get 'Covishield' vaccine for Rs 500-600, govt to get it at even lesser price

DNA Friday, 20 November 2020 ()
'Covishield', the frontrunner to India's race for Covid-19 vaccine, is manufactured by Serum Institute of India in agreement with Oxford-AstraZeneca.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Covid vaccine: How much will you have to pay? SII CEO reveals at #HTLS2020

Covid vaccine: How much will you have to pay? SII CEO reveals at #HTLS2020 03:50

Adar Poonawalla, CEO and owner of Serum Institute of India, the largest vaccine manufacturer in the world, revealed how much a Covid vaccine dose is likely to cost. He was speaking to Sanchita Sharma, health editor, Hindustan Times, on Day 1 of the 18th edition of the Hindustan Times Leadership...

💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP

India is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum Institute of India..
IndiaTimes
'Every 4-5 months, a new vaccine': SII CEO on India 'priority' #HTLS2020 [Video]

'Every 4-5 months, a new vaccine': SII CEO on India 'priority' #HTLS2020

Providing Covid vaccines to the Indian government and the Indian populace is the priority of the Serum Institute of India, the world's largest vaccine manufacturer. This was the message given by Adar Poonawalla, CEO and owner of SII at the 18th edition of the Hindustan Times Leadership Summit. In a conversation with Sanchita Sharma, health editor, HT, Poonawalla said that SII plans to launch a new vaccine every 4-5 months. Watch the full video for more.

Credit: HT Digital Content    Duration: 05:07Published

Covid vaccine should be available for public by April 2021: Serum Institute CEO

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly..
IndiaTimes

AstraZeneca British-Swedish pharmaceutical company

As race for vax nears last lap, Modi reviews India’s strategy

Prime Minister Narendra Modi on Friday held a review of India’s vaccination strategy amid indications that the fast-developing Oxford-AstraZeneca shot may be..
IndiaTimes
CDC warns against Thanksgiving travel [Video]

CDC warns against Thanksgiving travel

The Centers for Disease Control and Prevention on Thursday recommended Americans not travel during next week's Thanksgiving holiday to mitigate the spread of the coronavirus as cases of COVID-19 spike around the United States. This report produced by Yahaira Jacquez.

Credit: Reuters - Politics    Duration: 02:34Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

PM to review rise in COVID infections, vaccine roll-out with CMs

PM Narendra Modi is slated to review the coronavirus situation and discuss the roll-out of vaccine programmes with CMs of eight states, said sources.
DNA

PM Modi inaugurates multi-storeyed flats for MPs in New Delhi

Lok Sabha Speaker Om Birla was also present at the occasion. Eight bungalows, which were more than 80-years-old, have been redeveloped to construct 76 flats. The..
IndiaTimes
Maharashtra Anganwadi worker rows 18 km daily to ensure well-being of tribal babies [Video]

Maharashtra Anganwadi worker rows 18 km daily to ensure well-being of tribal babies

COVID-19 phase led to hardships for many, the pandemic has also severely affected healthcare facilities in rural areas. Meet Relu Vasave, an Anganwadi worker from Maharashtra's Nandurbar. Braving the pandemic, she rows 18 km daily to help the children under 6 years of age and expecting mothers in interior villages. She aims to provide nutritious food to pregnant mothers for good health. Tribals hailed her selfless efforts for assistance during the pandemic.

Credit: ANI    Duration: 02:29Published

Uttarakhand CM Trivendra Singh Rawat says Kumbh Mela in Haridwar to be held despite COVID challenges

Uttarakhand Chief Minister Trivendra Singh Rawat said that despite the practical problems that COVID-19 will be in its divine form.
DNA

You Might Like


Related videos from verified sources

'Every Delhiite will get health e-card': Kejriwal govt's new plan #HTLS2020 [Video]

'Every Delhiite will get health e-card': Kejriwal govt's new plan #HTLS2020

Speaking on Day 2 of the 18th edition of the Hindustan Times Leadership Summit, Arvind Kejriwal, Chief Minister of Delhi, announced a plan to link all of the capital's government health infrastructure..

Credit: HT Digital Content     Duration: 03:49Published
India will deliver COVID-19 vaccine in couple of months: Harsh Vardhan [Video]

India will deliver COVID-19 vaccine in couple of months: Harsh Vardhan

Amid encouraging final results of multiple vaccines for COVID-19 around the world, Union Health Minister Dr Harsh Vardhan on November 19 said that he is confident that India will deliver a vaccine in a..

Credit: ANI     Duration: 02:02Published
Bihar Polls 2020: BJP announces free vaccine for all in Bihar, faces heat | Oneindia News [Video]

Bihar Polls 2020: BJP announces free vaccine for all in Bihar, faces heat | Oneindia News

The BJP's free coronavirus vaccination for all promise in Bihar ahead of next week's election has become hugely controversial with the ruling party fending off allegations of an attempt to use the..

Credit: Oneindia     Duration: 02:24Published

Related news from verified sources

COVID-19: Cases rise but Maharashtra fatalities drop to all-time low of 50

COVID-19: Cases rise but Maharashtra fatalities drop to all-time low of 50
COVID-19 cases in Maharashtra rose by more than 5,700 cases again on Sunday taking its total tally to 17.80 lakh cases, however the number of COVID-related...
Mid-Day

Moderna COVID-19 vaccine to cost govts $25-$37 per dose: CEO

Governments seeking to purchase Moderna's potential COVID-19 vaccine may have to shell out $25 and $37 per dose, depending on the size of the order, the...
Mid-Day

SC seeks status report from Maharashtra, Delhi and Gujarat in 2 days over COVID-19 situation

The Supreme Court has sought an affidavit from Delhi, Maharashtra, Gujarat and Assam governments on the steps being taken in regard to the current COVID-19...
Mid-Day